The quest for Factor VIIa exosite inhibitors.

Area of Science:

• Biochemistry and Molecular Biology
• Pharmacology and Drug Discovery
• Hematology

Background:

• Blood coagulation is a critical proteolytic cascade involving enzymes like Factor VIIa.
• The extrinsic Xase complex, formed by Factor VIIa, tissue factor, and Factor X, initiates this cascade.
• Exosite interactions within the extrinsic Xase complex regulate its catalytic activity and conformation.

Purpose of the Study:

• To develop a novel assay for screening compounds targeting the extrinsic Xase complex.
• To identify potential anticoagulant drug leads from a large library of small molecules.
• To investigate the inhibition mechanisms of identified compounds.

Main Methods:

• Development of a continuous fluorescence polarization-based assay for extrinsic Xase activity.
• High-throughput screening of over one million structurally diverse small molecules.
• Deconvolution assays to categorize inhibitors as active-site or exosite-specific.

Main Results:

• Identification of numerous primary screen hits inhibiting extrinsic Xase activity.
• Categorization of hits into active-site and exosite inhibitors.
• Discovery of exosite inhibitors exhibiting both competitive and uncompetitive inhibition of Factor X activation.

Conclusions:

• A robust fluorescence polarization assay enables efficient screening for extrinsic Xase inhibitors.
• Uncompetitive inhibitors of the extrinsic Xase complex represent a promising strategy for anticoagulant development.
• This study provides a foundation for developing novel anticoagulants targeting the blood coagulation pathway.